SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Robert K. who wrote (7849)11/27/1998 9:13:00 AM
From: Tharos  Read Replies (2) | Respond to of 17367
 
As I "anticipate" a "possible" ,"response" from Robert S> regarding the "potential" of bpi's "limited" abilities vs sepsis

Why waste you're time? On another front, HIV, I found this interesting

*** Harvard scientists 'see' how HIV resists drugs

WASHINGTON (Reuters) - Scientists said Thursday they had been able to
"see" the changes that let the AIDS virus become resistant to drugs
and hope their images can help drug companies develop better ways to
attack the virus. Stephen Harrison and colleagues at the Howard
Hughes Medical Institute at Harvard University crystallized and made
an image of the reverse transcriptase enzyme that HIV uses to
replicate itself. They caught the virus just after it has attacked a
cell and used an instrument known as a synchrotron, which is a
high-intensity, high-energy X-ray crystallography machine, to image
the scene. See
infobeat.com
*** Also: Group accelerates search for AIDS vaccine, see
infobeat.com
*** And: European AIDS deaths drop 80% in 4 years, see
infobeat.com



To: Robert K. who wrote (7849)11/27/1998 1:07:00 PM
From: aknahow  Read Replies (3) | Respond to of 17367
 
Bob, I intend to read the prospectus with care, when I get a copy. I see nothing wrong with considering such a change. Will the facts support it? Don't know but am convinced there are good reasons to look into it. See below:

Advantages of Bermuda Registration

Overseas-owned (exempted or international) companies can be established in Bermuda to hold intellectual property
rights on software, or to develop and distribute software internationally, with full copyright protection. By
transferring their intellectual property assets to a Bermuda holding company, owners can license such rights to
entities based in other jurisdictions. This enables license fees and related income to accumulate in a tax neutral
jurisdiction, while having legal protection.

This type of arrangement may have some special appeal to people in the bio-technological, information,
pharmaceutical, publishing and scientific research industries. In the publishing industry, properties that would be
eligible include copyright of books, designs, graphics, and scripts of all kinds ranging from theatrical to music.


AND A BIT MORE

US royalty taxes avoidance

A US Tax Court ruling in 1996 made it clear that under certain conditions, companies can structure subsidiaries
incorporated and registered in Bermuda to either avoid completely or lower the withholding tax on royalties paid to such
an entity out of proceeds from a re-license into the USA. In a case involving a Bermuda-registered entity which received
such a payment from the USA, the USA's Internal Revenue Service tried to claim that the payment was US source
income and was therefore subject to the 30 percent withholding tax. But the Tax Court overruled this, saying that the
offshore company was not liable for this tax.

Expert legal counsel should be retained by any company seeking to explore the benefits that may arise in situations such
as this. But it does appear that opportunities exist to reduce or eliminate the US withholding tax under certain conditions.
For example, software and entertainment companies which own worldwide rights to the software, may be able to benefit
appreciably from a structuring or retructuring of their current royalty payments, if they have an appropriate corporate
vehicle owning these rights and incorporated and registered in Bermuda.